Price
CHART BY
Frequently asked questions
What is Aemetis's market capitalization?
What is the Earnings Per Share (EPS) for Aemetis?
What are the analyst ratings and target price for Aemetis's stock?
What is Aemetis's revenue over the trailing twelve months?
What is the EBITDA for Aemetis?
What is the free cash flow of Aemetis?
How many employees does Aemetis have, and what sector and industry does it belong to?
What is the free float of Aemetis's shares?
Financials
- Market Cap
- $114.39M
- EPS (TTM)
- -$2.256
- Free Float
- 45.36M
- Revenue (TTM)
- $291.40M
- EBITDA (TTM)
- -$27.56M
- Free Cashflow (TTM)
- -$14.38M
Pricing
- 1D span
- $2.296$2.309
- 52W span
- $2.05$7.02
Analyst Ratings
The price target is $11.55 and the stock is covered by 6 analysts.
Buy
3
Hold
3
Sell
0
Information
Aemetis, Inc. is a renewable fuels and biochemical company, which engages in the acquisition, development, and commercialization of technologies that replace traditional petroleum-based products. It operates through the North America and India geographical segments. The North America segment manages Keyes Plant in California, the cellulosic ethanol facility in Riverbank, the cluster of biogas digesters on dairies near Keyes, California, the Goodland Plant, Kansas and the research and development facility in Minnesota. The India segment refers to the Kakinada plant, administrative offices in Hyderabad, and holding companies in Nevada and Mauritius. Its products include glycerin, ethanol, food and feed, biodiesel, and edible oils. The company was founded by Eric Armstrong McAfee in 2006 and is headquartered in Cupertino, CA.
- Employees
- 205
- Industries
- Chemicals: Specialty
- Sector
- Materials
Identifier
- ISIN
- US00770K2024
- Primary Ticker
- AMTX